Does caffeine cause gynaecomastia? It is a question increasingly asked by men who consume coffee, energy drinks, or caffeine supplements and notice changes in their chest tissue. Gynaecomastia — the benign enlargement of glandular breast tissue in males — has a range of well-established hormonal, pharmacological, and medical causes. With caffeine being one of the most widely consumed substances in the world, understanding whether it plays any meaningful role is important. This article examines the current evidence, explores other lifestyle factors that may affect hormone balance, and explains when to seek medical advice.

What Is Gynaecomastia and What Causes It?

Gynaecomastia is benign glandular breast tissue enlargement in males caused by an oestrogen-to-androgen imbalance. Key causes include hormonal changes, certain medications, medical conditions such as hypogonadism, alcohol, cannabis, and obesity.

Gynaecomastia is the benign enlargement of glandular breast tissue in males, resulting from an imbalance between oestrogen and androgen (testosterone) activity in breast tissue. It is a relatively common condition, affecting an estimated 30–60% of males at some point during their lifetime, with peaks occurring during infancy, puberty, and older age. It is important to distinguish true gynaecomastia — which involves glandular tissue — from pseudogynaecomastia, which refers to fat deposition in the chest area without glandular involvement.

The underlying causes of gynaecomastia are varied and often multifactorial. Key contributing factors include:

• Hormonal changes during puberty or ageing, when testosterone levels naturally fluctuate

• Medications, including spironolactone, cimetidine, finasteride, antiandrogens, some antiretrovirals, anabolic steroids, and some antipsychotics — this list is not exhaustive; the BNF and NHS provide a fuller reference

• Medical conditions such as hypogonadism, hyperthyroidism, liver cirrhosis, and chronic kidney disease

• Recreational drug use, including cannabis, alcohol, and anabolic steroids

• Obesity, which increases peripheral conversion of androgens to oestrogens via aromatase activity in adipose tissue

• Topical products containing lavender or tea tree oil, which the NHS notes as potential contributors in some cases

In many cases, particularly in adolescent males, gynaecomastia is physiological and resolves without intervention. However, persistent or painful breast enlargement warrants clinical evaluation to rule out underlying pathology, including the rare possibility of male breast cancer. Understanding the root cause is essential before attributing the condition to any single dietary or lifestyle factor, such as caffeine consumption.

Important: if you are taking a prescribed medicine that you think may be contributing to breast tissue changes, do not stop taking it without first speaking to your doctor or pharmacist.

Is There a Link Between Caffeine and Gynaecomastia?

There is no established causal link between caffeine and gynaecomastia; it is not listed as an adverse effect in UK-regulated caffeine medicines and does not feature in NHS or NICE guidance on recognised causes.

Caffeine is one of the most widely consumed psychoactive substances in the world, found in coffee, tea, energy drinks, soft drinks, and certain medicines. Given its ubiquity, it is understandable that people may question whether regular caffeine intake could influence hormone levels and potentially contribute to conditions such as gynaecomastia.

At present, there is no established or officially recognised causal link between caffeine consumption and gynaecomastia. Gynaecomastia is not typically listed as an adverse effect in the Summary of Product Characteristics (SmPC) for UK-regulated caffeine-containing medicines (such as caffeine tablets or caffeine-containing analgesics), and it does not feature in NHS or NICE guidance on the recognised causes of the condition.

It is worth noting that most caffeinated beverages — coffee, tea, and soft drinks — are regulated as foods in the UK rather than as medicines, and are therefore not subject to SmPC adverse-effect reporting in the same way.

Some individuals and online communities have raised questions about whether caffeine might indirectly affect hormone balance. Caffeine has been shown in some studies to modestly influence cortisol and adrenaline secretion, particularly when consumed in large quantities. The European Food Safety Authority (EFSA) considers intakes of up to 400 mg per day (roughly three to four standard cups of coffee) to be safe for most healthy adults, with a lower threshold of 200 mg per day recommended during pregnancy. There is also limited, preliminary research suggesting that intakes substantially above these levels may have a minor effect on sex hormone-binding globulin (SHBG), which could theoretically influence the ratio of free testosterone to oestrogen. However, these findings are far from conclusive and have not been replicated consistently in clinical settings.

It is important to approach this topic with appropriate caution. Attributing gynaecomastia to caffeine without robust clinical evidence risks overlooking more clinically significant causes that require proper investigation and management. If you are concerned about breast tissue changes, a thorough medical assessment is always the appropriate first step.

What the Current Evidence Says

Current evidence does not support caffeine as a recognised cause of gynaecomastia. No robust human clinical trials confirm an association, and in vitro or animal findings cannot be reliably extrapolated to real-world risk.

A review of the available scientific literature reveals that the evidence linking caffeine directly to gynaecomastia is extremely limited and largely speculative. No large-scale, peer-reviewed clinical trials have demonstrated a statistically significant association between caffeine intake and the development of gynaecomastia in males.

Some animal studies have explored caffeine's effects on endocrine function, including its potential to influence oestrogen receptor activity. A small number of in vitro (laboratory) studies have suggested that certain compounds found in coffee — not caffeine itself — may have weak oestrogenic properties. However, in vitro and animal data do not reliably predict clinical outcomes in humans, and extrapolating these findings to real-world risk is not scientifically justified without robust human evidence.

It is also worth noting that many energy drinks and pre-workout supplements that contain high doses of caffeine also include other ingredients — such as guarana, taurine, B vitamins, artificial sweeteners, and various herbal extracts — that may have their own physiological effects. Isolating caffeine as a causative agent in any reported cases is therefore methodologically challenging, and caution should be applied when interpreting anecdotal reports.

In summary, the current evidence does not support caffeine as a recognised cause of gynaecomastia. The condition is far more commonly associated with well-established hormonal, pharmacological, and medical causes. Clinicians and patients should be cautious about drawing conclusions from anecdotal reports or low-quality online sources. If gynaecomastia develops or worsens, a structured clinical assessment — rather than dietary modification alone — is the recommended course of action.

Other Lifestyle and Dietary Factors That May Affect Hormone Balance

Alcohol, cannabis, obesity, anabolic steroids, and topical products containing lavender or tea tree oil have more credible associations with hormonal imbalance and gynaecomastia than caffeine.

While caffeine does not appear to be a meaningful contributor to gynaecomastia, several other lifestyle and dietary factors have more credible associations with hormonal imbalance and breast tissue changes in males.

Alcohol is one of the most well-documented contributors. Chronic alcohol use can impair liver function, reducing the liver's ability to metabolise oestrogens effectively. It may also directly suppress testosterone production, shifting the oestrogen-to-androgen ratio in favour of oestrogen. The NHS lists alcohol as a recognised potential cause of gynaecomastia.

Cannabis has been associated with gynaecomastia in several case reports and observational studies. The phytocannabinoids in cannabis are thought to interact with androgen receptors and may suppress testosterone synthesis, though the evidence base remains limited. The NHS acknowledges cannabis as a potential contributing factor.

Dietary phytoestrogens — plant-derived compounds with weak oestrogenic activity — are found in soy products, flaxseeds, and certain herbal supplements. While moderate dietary intake is generally considered safe, very high consumption has been linked in isolated case reports to hormonal effects, including gynaecomastia.

Topical products containing lavender oil or tea tree oil have been cited by the NHS as potential contributors to gynaecomastia, possibly due to weak endocrine-disrupting properties.

Additional lifestyle factors to consider include:

• Obesity: Excess adipose tissue increases aromatase activity, converting androgens to oestrogens

• Anabolic steroid use: A well-established cause of gynaecomastia due to aromatisation of exogenous androgens; unregulated supplements carrying hidden anabolic agents pose a similar risk

• Stress and sleep deprivation: Both can elevate cortisol, which may suppress testosterone over time, though a direct causal link to gynaecomastia has not been firmly established in clinical studies

Maintaining a balanced diet, limiting alcohol, avoiding illicit substances and unregulated supplements, and achieving a healthy body weight are all evidence-supported strategies for supporting hormonal health.

If you suspect that a medicine, supplement, or herbal product may be causing or worsening gynaecomastia, you can report this via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk.

When to Speak to a GP About Gynaecomastia

See your GP promptly if you notice persistent breast enlargement, pain, a hard or irregular lump, nipple discharge, or skin changes. NICE NG12 recommends urgent two-week-wait referral for men with unexplained breast or nipple changes.

Many cases of gynaecomastia — particularly in adolescent males — are physiological and resolve spontaneously within six to twenty-four months. However, there are circumstances in which it is important to seek prompt medical advice rather than waiting or attempting self-management.

You should contact your GP if you notice:

• Breast tissue enlargement that is persistent (lasting more than two years)

• Pain, tenderness, or discomfort in the breast area

• A hard, irregular, or fixed lump — which requires urgent assessment to exclude malignancy

• Nipple discharge of any kind, particularly if blood-stained

• Nipple retraction or skin changes such as dimpling or peau d'orange

• Rapid or unexplained breast growth, particularly if unilateral

• A lump or swelling in the armpit (axillary lymphadenopathy)

• A testicular mass or swelling

• Associated symptoms such as fatigue, reduced libido, erectile dysfunction, or unexplained weight changes

Urgent referral: In line with NICE guideline NG12 (Suspected cancer: recognition and referral), GPs should consider an urgent two-week-wait referral to a breast clinic for men with an unexplained breast lump, nipple changes, skin changes, or an axillary lump — particularly in men aged 50 and over. If you have any of these features, your GP should assess you promptly.

Your GP will typically take a thorough medical and medication history, as many prescription and over-the-counter medicines are known to cause gynaecomastia. Do not stop any prescribed medicine without first discussing this with your doctor. A physical examination will be performed, including assessment of the testes, and blood tests may be requested to assess hormone levels (including testosterone, oestradiol, LH, FSH, prolactin, and beta-hCG where a tumour is suspected), as well as liver and kidney function and thyroid function.

In cases where the cause is unclear or where a testicular or adrenal tumour is suspected, imaging — such as testicular ultrasound — may be arranged. Suspicious breast findings should be directed to an urgent breast clinic rather than managed solely in primary care. Please be open and honest with your GP about all substances you consume, including supplements, herbal products, recreational drugs, and high-dose caffeine products, as these details can be clinically relevant.

NHS Guidance and Treatment Options for Gynaecomastia

Most gynaecomastia cases require only reassurance and monitoring; where treatment is needed, options include off-label tamoxifen, surgical reduction, or psychological support, all initiated under medical supervision.

The NHS acknowledges gynaecomastia as a common and usually benign condition. According to NHS guidance, most cases do not require active treatment, particularly when the cause is identified and addressed — for example, by stopping a causative medication (only under medical supervision) or treating an underlying medical condition. Reassurance and monitoring are often sufficient, especially in adolescent males experiencing pubertal gynaecomastia.

Where treatment is considered necessary, options include:

• Pharmacological treatment: Tamoxifen (a selective oestrogen receptor modulator, SERM) may be used off-label in some cases, particularly when gynaecomastia is painful or has been present for less than twelve months — medical therapy is generally more effective before fibrotic changes become established. Anastrozole (an aromatase inhibitor) has also been used off-label, but the evidence supporting its use is more limited than for tamoxifen. Both agents are specialist-initiated and are not universally available on the NHS. Do not attempt to obtain tamoxifen, anastrozole, or similar medicines online or without medical supervision, as their use requires appropriate assessment and monitoring for adverse effects.

• Surgical treatment: Surgical reduction (mastectomy or liposuction) may be considered for longstanding or severe gynaecomastia that causes significant psychological distress. NHS commissioning policies vary by Integrated Care Board (ICB) and may require an Individual Funding Request (IFR). Referral is typically made via a GP to a plastic or breast surgeon.

• Psychological support: For individuals experiencing significant distress related to body image, referral to psychological services may be appropriate alongside physical treatment.

It is important to note that no dietary supplement or lifestyle change — including reducing caffeine intake — has been clinically validated as a treatment for gynaecomastia. If you are concerned about breast tissue changes, the most effective course of action is to seek a formal medical assessment through your GP, who can guide you through the appropriate NHS pathway based on your individual circumstances.

Have questions about your medication? Our pharmacists are here to help →

If you believe a medicine or supplement has contributed to gynaecomastia, you or your healthcare professional can report this to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk.

Frequently Asked Questions